NiKang Therapeutics Inc.

NiKang Therapeutics is a clinical-stage biotechnology company founded in 2017. They are dedicated to developing innovative small molecule drugs for the treatment of cancer, focusing on difficult-to-drug targets like HIF2α, CDK2, and KRAS. Their approach combines disease biology insights and structure-based drug design, leading to the advancement of several small molecule drugs into first-in-human clinical testing. NiKang's mission is to develop precision medicines that address unmet medical needs in oncology and improve patient outcomes.

The company has a strong leadership team with extensive experience in the biotechnology and pharmaceutical industries. They have successfully raised significant funding through multiple financing rounds and have established collaborations with major pharmaceutical companies like Pfizer and Roche. NiKang's commitment to innovation, coupled with their scientific expertise and strategic partnerships, positions them as a promising player in the fight against cancer.

NiKang Therapeutics offers a remote work environment for all non-lab positions, providing flexibility to employees. This allows for a work-life balance and the opportunity to work from anywhere, as long as the required tasks can be completed remotely.

NiKang Therapeutics offers a competitive benefits package focused on financial security and health & wellness. This includes competitive salaries with annual reviews, a stock plan with new hire and annual grant eligibility, an annual bonus plan, flexible spending accounts, and a 401(k) plan with a 4% employer match. For health and wellness, they offer a remote work environment for all non-lab positions, an Aetna medical and prescription drug plan with above-market employer contributions, company-paid dental and vision coverage, life and disability insurances, and paid time off.

NiKang Therapeutics is a clinical-stage biotech company dedicated to developing innovative small molecule drugs to address unmet medical needs, specifically in the field of cancer. Their mission is to create precision medicine that helps patients fight cancer and live better lives by conquering scientific challenges and pushing the boundaries of oncology research.

NiKang Therapeutics promotes a culture focused on scientific innovation, collaboration, and a deep commitment to developing groundbreaking cancer therapies. They value nimbleness, integrity, knowledge sharing, accountability, and a drive for novelty, encouraging their team to push boundaries and strive for excellence in their quest to combat cancer.

NiKang Therapeutics is committed to fostering a diverse, equitable, and inclusive workplace. They value the unique perspectives and experiences of all employees and strive to create an environment where everyone feels respected, valued, and empowered to contribute their best work. This commitment is reflected in their core values, which emphasize knowledge and collaboration, accountability, and forging new horizons. NiKang actively seeks to attract, develop, and retain a diverse workforce and promotes equal opportunities for all employees.